safety monitoring
Articles tagged with “safety monitoring”
Low-Dose Ketamine Eligibility: Who Qualifies for Treatment
Learn the diagnosis, screening, and contraindication factors that determine low-dose ketamine eligibility, and see what to ask your clinician.
Ketamine Therapy and Mania Risk in Bipolar Disorder
Ketamine can trigger mood switches in bipolar disorder. Learn the evidence on mania risk, screening safeguards, and monitoring before treatment.
Low-Dose Ketamine for Late-Life Depression: Medications
Learn how clinicians assess low-dose ketamine for late-life depression with multiple medications, risks, monitoring, and questions to ask.
Ketamine and Alcohol: Interaction Risks Explained
Alcohol and low-dose ketamine both depress the CNS. Learn the interaction risks, why prescribers set alcohol-free windows, and what to ask your clinician.
How Far Apart Should Low-Dose Ketamine Treatments Be Spaced?
Low-dose ketamine spacing depends on treatment phase: 2-3x weekly during induction, then every 2-4 weeks for maintenance. See what the evidence supports.
Low Dose Ketamine Drug Test Detection: What to Know
Learn why low dose ketamine drug test detection depends on the test, sample, timing, and whether ketamine is specifically included.
Low Dose Ketamine Urinary Tract Long-Term Safety
What patients should know about low dose ketamine urinary tract long-term safety, including monitoring, warning signs, and questions to ask your prescriber.
Ketamine Therapy for Older Adults: Safety Considerations
What older adults and families should know about ketamine therapy safety, blood pressure monitoring, drug interactions, and clinical evidence.
PHQ-9 and GAD-7 in Ketamine Dose Adjustment: A Patient Guide
Learn how PHQ-9 and GAD-7 assessments guide ketamine dose adjustments. Patient-focused guide to understanding symptom tracking and dosing decisions.
Ketamine Side Effects & When to Switch: New Clinical Guidance
New clinical guidance urges tracking PHQ-9 scores, monitoring side effects closely, and switching NMDA treatments sooner to reach remission faster.
Ketamine Therapy in Rural Communities: Overcoming Access Barriers
Learn how rural patients can assess ketamine therapy access, including telehealth, regional care models, safety planning, travel, and cost questions.
Ketamine and Liver Function Tests: Monitoring LFTs During Therapy
How and when to monitor liver function tests during low-dose ketamine therapy, including baseline panels, testing schedules, and abnormal LFT thresholds.
Low-Dose Ketamine for Eating Disorders: Anorexia, Bulimia, and Binge Eating
Learn what limited research says about low dose ketamine for anorexia, bulimia, and binge-eating disorder, plus safety and care coordination considerations.
Ketamine and SSRIs: Drug Interaction Deep Dive
Can you take ketamine while on an SSRI? Review the serotonin syndrome risk, drug interaction evidence, and monitoring steps clinicians recommend.
Low-Dose Ketamine and Cannabis: What Patients Should Know
Learn what is known about low dose ketamine and cannabis, including overlapping effects, cautious timing guidance, CBD considerations, and questions to discuss with your clinician.
How to Start a Ketamine Therapy Practice: A Clinician's Guide
A clinician guide to starting a ketamine therapy practice, covering registration, state review, protocols, monitoring, compounding, documentation, staffing, and referrals.
Low-Dose Ketamine Case Studies: Clinical Outcomes and Lessons
Review five low-dose ketamine composite case studies, including depression, PTSD, CRPS, bipolar depression, and suicidal ideation, with research-backed clinical lessons.
Ketamine and Benzodiazepines: Clinical Interaction Guide
How benzodiazepines affect ketamine's antidepressant response: GABA vs. glutamate mechanisms, dosing strategies, taper timing, and what the clinical evidence shows.
Tracking Treatment Response to Ketamine: PHQ-9, MADRS, and Clinical Scales
Learn how PHQ-9, MADRS, QIDS-SR, and safety measures can track ketamine treatment response and support informed clinical follow-up.
Low-Dose Ketamine and Alcohol: Patient Safety Guide
Low dose ketamine and alcohol should not be combined. Learn the interaction risks, screening steps, and 24-hour abstinence guidelines for safe treatment.
Drug Interactions and Contraindications
Learn which medications, substances, and health conditions may require extra caution before ketamine treatment, and what to discuss with a clinician.
IV vs Oral Ketamine: Routes of Administration Compared
Compare IV and oral ketamine for depression, including absorption, research evidence, monitoring, convenience, safety planning, and questions to ask a prescriber.
Dosing and Administration
Learn how ketamine and esketamine dosing and administration differ, why clinical monitoring matters, and which questions to ask your prescriber.
Safety and Side Effects
Learn about common low-dose ketamine side effects, serious safety considerations, driving restrictions, medication review, and questions to ask a clinician.
The Ketamine Treatment Process
Learn what a ketamine treatment process for PTSD may involve, including assessment, preparation, monitoring, recovery, and questions to ask a clinician.
Getting Started with Ketamine Therapy
Learn how to begin a clinician-guided ketamine therapy evaluation, including provider questions, medication review, safety planning, and practical preparation.
Does Ketamine Work for Anxiety?
Ketamine may reduce anxiety symptoms for some people, but there is no standard anxiety dose. Review the research, limits, safety questions, and next steps.
Does Ketamine Help with PTSD?
Ketamine for PTSD may reduce symptoms rapidly in some studies, but it is not first-line care. Review research, safety questions, and treatment limits.
What Happens During a Ketamine Infusion?
The standard ketamine infusion dose is 0.5 mg/kg over 40 minutes. Learn what to expect before, during, and after your appointment.
Telehealth Ketamine Therapy: Protocols and Best Practices
How does telehealth ketamine therapy work? A guide to DEA telemedicine rules, sublingual dosing, at-home monitoring, and patient selection criteria.
Low-Dose Ketamine for Postpartum Depression
Learn what research says about low-dose ketamine for postpartum depression, including limits of the evidence, breastfeeding questions, monitoring, and treatment discussions.
Ketamine and Bladder Health: Urological Safety at Therapeutic Doses
Learn how ketamine and bladder health interact, including cystitis mechanisms, dose-response evidence, and monitoring steps for safe therapeutic use.
Ketamine in Pregnancy and Lactation: Safety Considerations and Data Gaps
What research shows about ketamine safety in pregnancy and lactation, including preclinical data, placental transfer, breastfeeding guidance, and evidence gaps.
Clinical Monitoring During Ketamine Administration: Assessment Protocols
See how online medical assessment and in-person clinical monitoring work together during ketamine treatment, from pre-treatment screening to discharge criteria.
Pediatric Low-Dose Ketamine: Dosing Considerations and Safety
Pediatric low-dose ketamine dosing considerations and safety, including age-related differences, evidence limits, monitoring, consent, and questions for families.
Low-Dose Ketamine Infusions for Neuropathic Pain: Evidence and Protocols
Learn what evidence supports low-dose ketamine infusions for neuropathic pain, where benefits are most established, and what monitoring questions to ask.
Ketamine-Assisted Psychotherapy: Integrating Pharmacology and Psychotherapy
Learn how ketamine-assisted psychotherapy combines ketamine, preparation, and integration therapy, what the evidence shows, and what to ask a KAP program.
Telehealth Ketamine Marketing Compliance: Regulatory and Ethical Guidelines
Learn how telehealth ketamine marketing can address off-label use, FTC health claims, DEA telemedicine rules, REMS distinctions, and state-specific review needs.
Ketamine Side Effects: A Complete Clinical Guide
A complete review of ketamine side effects, from dissociation and nausea to blood pressure changes and cognitive effects, with incidence rates and monitoring guidance for low-dose treatment.
Managing Nausea and Vomiting During Ketamine Therapy
Ketamine-induced nausea is common but manageable. Learn the causes, risk factors, and antiemetic protocols clinicians use to prevent and treat it.
Esketamine vs Racemic Ketamine Dosing: Comparative Pharmacology
Compare esketamine and racemic ketamine dosing by route, formulation, monitoring, treatment schedule, and the questions to ask a clinician.
Ketamine-Assisted Therapy for Substance Use Disorders: Clinical Trials Review
A source-backed review of ketamine-assisted therapy for substance use disorders, including early alcohol and cocaine trial findings, safety considerations, and limits of the evidence.
Ketamine Combination Therapy: Augmentation Strategies with Existing Treatments
Learn what current evidence says about ketamine combination therapy with antidepressants, benzodiazepines, mood stabilizers, and psychotherapy.
Low-Dose Ketamine for Social Anxiety Disorder: Preliminary Evidence
Learn what early studies show about low dose ketamine for anxiety and social anxiety disorder, including limits of the evidence, safety considerations, and questions to ask.
Informed Consent for Ketamine Treatment: Essential Elements
Learn the essential elements of informed consent for ketamine treatment, including off-label disclosure, risks, alternatives, monitoring, and patient rights.
Ketamine-Opioid System Interactions: Naltrexone Studies and Debate
How ketamine interacts with opioid receptors, what the naltrexone blockade study found, and what it means for patients on opioid medications.
Ketamine Maintenance Infusion Protocols: Frequency and Duration Optimization
Learn what research supports about ketamine maintenance infusion protocols, including induction, treatment frequency, tapering, duration, monitoring, and relapse planning.
Low-Dose Ketamine for Anxiety Disorders
Learn what research says about low dose ketamine for anxiety, including GAD, social anxiety, OCD, safety monitoring, and questions to ask a clinician.
Low-Dose Ketamine for Bipolar Depression: Efficacy and Safety Data
Review the evidence for low-dose ketamine in bipolar depression, including rapid response findings, affective switch concerns, monitoring, and FDA approval limits.
Long-Term Safety Considerations for Ketamine Therapy
Does ketamine cause long-term memory loss? Review the evidence on cognitive, bladder, liver, and dependence risks from extended low-dose ketamine therapy.
Clinically Significant Drug Interactions with Low-Dose Ketamine
Learn which medicines and substances may interact with low dose ketamine, what the evidence shows, and what to discuss with your prescribing clinician.
Weight-Based Dosing Guidelines for Low-Dose Ketamine
Understand the 0.5 mg/kg IV ketamine research reference, why routes differ, and what to ask about weight-based dosing and follow-up.
Ketamine-Assisted Therapy for PTSD and Trauma
Learn what research says about ketamine therapy for PTSD, its limits, safety considerations, and how it may fit with trauma-focused treatment.
Telemedicine Monitoring Protocols for At-Home Ketamine Therapy
Learn how to prepare for an at-home ketamine therapy session, including companion planning, home setup, remote monitoring, follow-up, and questions for your clinician.
Contraindications and Screening Protocols for Ketamine Therapy
Learn which conditions rule out ketamine therapy, which need closer monitoring, and when TMS may be a better fit. Includes the full screening protocol.
Standard IV Ketamine Infusion Protocols for Treatment-Resistant Depression
Learn how IV ketamine infusion protocols for treatment-resistant depression are commonly structured, monitored, and evaluated, including the 0.5 mg/kg research regimen.
Spravato (Esketamine) Nasal Spray Protocol and Administration Guidelines
Learn Spravato administration requirements, including REMS-certified dosing, two-hour monitoring, treatment schedules, safety checks, and discharge planning.
Geriatric Considerations in Low-Dose Ketamine Therapy
Learn how low dose ketamine therapy may be considered for older adults, including cardiovascular screening, cognitive concerns, fall prevention, and evidence limits.
Low-Dose Ketamine for Chronic Pain Syndromes
Learn when low dose ketamine may be considered for CRPS, neuropathic pain, and fibromyalgia, what research supports, and what to discuss with a pain clinician.
Pharmacokinetics of Ketamine: Absorption, Distribution, Metabolism, and Elimination
Learn how ketamine is absorbed, distributed, metabolized, and eliminated across IV, intranasal, oral, sublingual, IM, and subcutaneous routes.
Renal and Hepatic Dose Adjustments for Low-Dose Ketamine
Learn how liver and kidney impairment can affect low-dose ketamine planning, monitoring, recovery, and questions to ask a prescribing clinician.
Low-Dose Ketamine for Treatment-Resistant Depression
Learn what research says about low dose ketamine for treatment-resistant depression, including rapid effects, safety monitoring, esketamine, and questions to ask a clinician.
Dose-Response Relationships in Low-Dose Ketamine Therapy
Learn why low dose ketamine therapy does not have one universal dose, how route and treatment goals affect response, and which questions to bring to follow-up.
Patient Selection Criteria for Low-Dose Ketamine Therapy
Learn how clinicians assess candidates for low dose ketamine therapy, including diagnosis, treatment history, safety screening, practical readiness, and monitoring.
Contact Low Dose Ketamine
Send corrections, provider questions, or advertising inquiries.